Cobblestone Capital Advisors’s AstraZeneca AZN Stock Holding History

Cobblestone Capital Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$275K	Buy	1,791 +204	+13%	+$30.9K	0.01%	265
2025 Q2	$222K	Sell	1,587 -1,500	-49%	-$210K	0.01%	287
2025 Q1	$454K	Buy	3,087 +1,322	+75%	+$191K	0.02%	199
2024 Q4	$231K	Hold	1,765	–	–	0.01%	269
2024 Q3	$275K	Hold	1,765	–	–	0.02%	247
2024 Q2	$275K	Buy	1,765 +77	+5%	+$11.6K	0.02%	237
2024 Q1	$229K	Hold	1,688	–	–	0.01%	258
2023 Q4	$227K	Hold	1,688	–	–	0.02%	251
2023 Q3	$229K	Hold	1,688	–	–	0.02%	238
2023 Q2	$242K	Hold	1,688	–	–	0.02%	242
2023 Q1	$234K	Hold	1,688	–	–	0.02%	237
2022 Q4	$229K	Buy	+1,688	New	+$212K	0.02%	252
2022 Q3	–	Sell	-1,638	Closed	-$216K	–	258
2022 Q2	$216K	Buy	+1,638	New	+$215K	0.02%	235
2020 Q2	–	Sell	-3,355	Closed	-$300K	–	247
2020 Q1	$300K	Buy	+3,355	New	+$316K	0.03%	196

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cobblestone Capital Advisors's AZN Position: Q3 2025 in Review

Cobblestone Capital Advisors increased its AstraZeneca (AZN) stake by 13% in Q3 2025, buying an estimated $30.9K and bringing the position to 1,791 shares worth $275K. The position accounts for 0.01% of the portfolio, ranked #265.

Cobblestone Capital Advisors first reported a position in AZN in Q1 2020 and has held it in 14 quarters since. The position peaked at $454K in Q1 2025. 1,287 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Cobblestone Capital Advisors held 1,791 shares of AstraZeneca worth $275K as of Q3 2025.
Cobblestone Capital Advisors bought 204 AstraZeneca shares in Q3 2025, an estimated $30.9K.
AstraZeneca made up 0.01% of Cobblestone Capital Advisors's portfolio in Q3 2025, its #265 holding.
Cobblestone Capital Advisors first reported a position in AstraZeneca in Q1 2020 and has held it in 14 quarters since.
Cobblestone Capital Advisors's AstraZeneca position peaked at $454K in Q1 2025.
1,287 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Cobblestone Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.